Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Return on Equity (2019 - 2025)

Silo Pharma's Return on Equity history spans 7 years, with the latest figure at 1.02% for Q3 2025.

  • For Q3 2025, Return on Equity fell 44.0% year-over-year to 1.02%; the TTM value through Sep 2025 reached 1.02%, down 44.0%, while the annual FY2024 figure was 0.78%, 78.0% down from the prior year.
  • Return on Equity for Q3 2025 was 1.02% at Silo Pharma, up from 1.1% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.0% in Q4 2022 and bottomed at 1.1% in Q2 2025.
  • The 5-year median for Return on Equity is 0.44% (2023), against an average of 0.44%.
  • The largest YoY upside for Return on Equity was 161bps in 2021 against a maximum downside of -799bps in 2021.
  • A 5-year view of Return on Equity shows it stood at 0.05% in 2021, then soared by 100bps to 0.0% in 2022, then crashed by -633182bps to 0.66% in 2023, then decreased by -12bps to 0.74% in 2024, then plummeted by -38bps to 1.02% in 2025.
  • Per Business Quant, the three most recent readings for SILO's Return on Equity are 1.02% (Q3 2025), 1.1% (Q2 2025), and 1.02% (Q1 2025).